Page 23 - Astrazeneca
SII will sell vaccine for Rs 200 to govt, Rs 1,000 to public: Report
He said that the vaccine will be rolled out in the next 7 to 10 days
 "SII will sell vaccine for Rs 200 to govt, Rs 1,000 to public: Report")
Russia ready to trial combined AstraZeneca, Sputnik V vaccine in Ukraine
Russia's sovereign RDIF, which is marketing the Sputnik V vaccine abroad, announced in December trials to test a combination of the AstraZeneca vaccine with the Sputnik V
 "Russia ready to trial combined AstraZeneca, Sputnik V vaccine in Ukraine")
India approves AstraZeneca's Covid-19 vaccine for emergency use
It is the first Covid-19 vaccine to be approved for emergency use by India, which has the highest number of infections after the United States
 "India approves AstraZeneca's Covid-19 vaccine for emergency use")
Covishield moves closer to roll-out; SII gets in-principle nod from panel
India would need 30 million doses in the first phase when it vaccinates the essential services workers including health care professionals, municipal and police staff, etc
 "Covishield moves closer to roll-out; SII gets in-principle nod from panel")
Top headlines: Companies hold back on capex, GST mop-up at record high
Business Standard brings you top news of the evening
 "Top headlines: Companies hold back on capex, GST mop-up at record high")
AstraZeneca vaccine set to become first to get approval in India: Report
The decision would pave the way for the vaccine's rollout in the world's second-most populous country
Drug controller hints vaccine approval will make it a 'happy new year'
V G Somani's statement comes even as subject expert committee is set to meet on Jan 1 to consider three emergency-use authorisation applications
 "Drug controller hints vaccine approval will make it a 'happy new year'")
Argentina authorises use of AstraZeneca vaccine against coronavirus
Argentina's National Administration of Drugs, Foods and Medical Devices (ANMAT) on Wednesday approved the use of vaccine from AstraZeneca, against Covid-19 in the country
India will have coronavirus vaccine within days, says AIIMS Director
Terming the approval for Oxford-AstraZeneca vaccine for use in the UK as a "big step forward", AIIMS Delhi Director Dr Randeep Guleria said that India will have the Covid-19 vaccine within days
 "India will have coronavirus vaccine within days, says AIIMS Director")
Easy to store and cheaper, Oxford's Covid shot may be vaccine for the world
Astra vaccine accounts for more than 40% of supplies going to low- and middle-income nations
 "Easy to store and cheaper, Oxford's Covid shot may be vaccine for the world")
India's Covid vaccine hope rolls over to 2021; panel to meet again on Jan 1
Sources close to the development said the expert committee sought more information from Serum Institute regarding the Oxford-AstraZeneca vaccine
Drug regulator to meet again on Jan 1 to discuss AstraZeneca vaccine
India is also considering emergency-use authorisation applications for vaccines made by Pfizer Inc with Germany's BioNTech, and by India's Bharat Biotech
India drug regulator meets to discuss AstraZeneca vaccine: Report
SII, the world's biggest producer of vaccines, has already stockpiled about 50 million doses, enough for 25 million people
UK becomes world's first nation to approve AstraZeneca-Oxford Covid vaccine
The government has today accepted the recommendation to authorise Oxford University/AstraZeneca's Covid-19 vaccine for use, the health ministry said
AstraZeneca's Covid-19 vaccine not ready for quick EU nod: Regulator
Pakistan, Japan find cases with new coronavirus variants on their own soil
 "AstraZeneca's Covid-19 vaccine not ready for quick EU nod: Regulator")
UK set to clear Astra shot; Novavax starts late-stage trial in US
Lockdowns in UK could ease in weeks with introduction of another vaccine
Nod for Covid vaccine in the next few days: Serum Institute's Poonawalla
SII has stockpiled 40-50 mn doses and is adding more every week. Most of these will come to India, as exporting would require fulfilling WHO's pre-qualification procedures
Oxford/AstraZeneca vaccine should be effective against new variant: Report
The coronavirus vaccine developed by Oxford University and AstraZeneca should be effective against the highly transmissible new strain of the virus, the report said
We are researching two candidates for Covid vaccines: Serum Institute CEO
In an e-mail interview with Sohini Das, Adar Poonawalla, chief executive officer, Serum Institute of India, says the firm is not raising additional capital through private equity
AstraZeneca submitted data for MHRA approval, says UK Health Minister
UK health secretary said that AstraZeneca had submitted a full data package about its Covid-19 vaccine to the Medicines and Healthcare products Regulatory Agency (MHRA) for approval
 "AstraZeneca submitted data for MHRA approval, says UK Health Minister")